- Home
- UHS vs ICLR Comparison
UHS vs ICLR Comparison
Compare UHS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHS
- ICLR
- Stock Information
- Founded
- UHS 1978
- ICLR 1990
- Country
- UHS United States
- ICLR Ireland
- Employees
- UHS N/A
- ICLR N/A
- Industry
- UHS Hospital/Nursing Management
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- UHS Health Care
- ICLR Health Care
- Exchange
- UHS Nasdaq
- ICLR Nasdaq
- Market Cap
- UHS 11.7B
- ICLR 11.5B
- IPO Year
- UHS N/A
- ICLR 1998
- Fundamental
- Price
- UHS $181.75
- ICLR $133.96
- Analyst Decision
- UHS Buy
- ICLR Buy
- Analyst Count
- UHS 17
- ICLR 12
- Target Price
- UHS $222.31
- ICLR $206.64
- AVG Volume (30 Days)
- UHS 846.0K
- ICLR 2.1M
- Earning Date
- UHS 04-28-2025
- ICLR 04-30-2025
- Dividend Yield
- UHS 0.44%
- ICLR N/A
- EPS Growth
- UHS 51.30
- ICLR 11.53
- EPS
- UHS 17.80
- ICLR 9.19
- Revenue
- UHS $16,084,073,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- UHS $9.55
- ICLR $1.63
- Revenue Next Year
- UHS $5.42
- ICLR $4.82
- P/E Ratio
- UHS $10.22
- ICLR $15.07
- Revenue Growth
- UHS 9.73
- ICLR N/A
- 52 Week Low
- UHS $153.99
- ICLR $133.28
- 52 Week High
- UHS $243.25
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- UHS 54.48
- ICLR 33.96
- Support Level
- UHS $175.41
- ICLR $135.00
- Resistance Level
- UHS $187.98
- ICLR $141.96
- Average True Range (ATR)
- UHS 5.90
- ICLR 6.69
- MACD
- UHS 1.58
- ICLR 0.43
- Stochastic Oscillator
- UHS 79.49
- ICLR 3.63
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.